GAMA
CDNA icon

Graticule Asia Macro Advisors’s CareDx CDNA Stock Holding History

Graticule Asia Macro Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,000
Closed -$1.7M – 153
2021
Q1 		$1.7M Buy
+25,000
New +$1.94M 0.28% 97

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Graticule Asia Macro Advisors's CDNA Position: Q2 2021 in Review

Graticule Asia Macro Advisors sold out of CareDx (CDNA) in Q2 2021, closing a stake of 25,000 shares — an estimated $1.7M sold.

Graticule Asia Macro Advisors first reported a position in CDNA in Q1 2021 and held it in 1 quarter. The position peaked at $1.7M in Q1 2021. 254 funds tracked by Wall St. Rank hold CDNA as of Q2 2021.

  • Graticule Asia Macro Advisors reported no remaining CareDx position as of Q2 2021 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 25,000 CareDx shares in Q2 2021, an estimated $1.7M.
  • Graticule Asia Macro Advisors first reported a position in CareDx in Q1 2021 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's CareDx position peaked at $1.7M in Q1 2021.
  • 254 funds tracked by Wall St. Rank held CareDx as of Q2 2021.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.